Michael J. Allegrezza
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Immune Cell Function and Interaction, CAR-T cell therapy research, Immune cells in cancer, Immunotherapy and Immune Responses
Most-Cited Works
- → BET Bromodomain Inhibition Promotes Anti-tumor Immunity by Suppressing PD-L1 Expression(2016)425 cited
- → Age Correlates with Response to Anti-PD1, Reflecting Age-Related Differences in Intratumoral Effector and Regulatory T-Cell Populations(2018)356 cited
- → Microbially Driven TLR5-Dependent Signaling Governs Distal Malignant Progression through Tumor-Promoting Inflammation(2014)302 cited
- → Tumor Cell–Independent Estrogen Signaling Drives Disease Progression through Mobilization of Myeloid-Derived Suppressor Cells(2016)217 cited
- → SATB1 Expression Governs Epigenetic Repression of PD-1 in Tumor-Reactive T Cells(2017)154 cited
- → Follicle-Stimulating Hormone Receptor Is Expressed by Most Ovarian Cancer Subtypes and Is a Safe and Effective Immunotherapeutic Target(2016)118 cited
- → Transforming Growth Factor β-Mediated Suppression of Antitumor T Cells Requires FoxP1 Transcription Factor Expression(2014)115 cited
- → Satb1 Overexpression Drives Tumor-Promoting Activities in Cancer-Associated Dendritic Cells(2016)107 cited
- → Frontline Science: Microbiota reconstitution restores intestinal integrity after cisplatin therapy(2018)87 cited
- → Targeted Therapy and Immunosuppression in the Tumor Microenvironment(2016)80 cited